THE NEW POSSIBLE
November 14 – 15, 2018 • Harvard Medical School, Boston, MA
The 14th Annual Personalized Medicine Conference: Preparing for the New Possible will convene the world’s leading researchers, investors, industry executives, policy experts, payers, clinicians, and patient advocates to define the landscape and outlook for personalized medicine in science, business, and policy. Participants will examine the infrastructure and business strategies necessary to overcome scientific obstacles, optimize public policies, and change embedded medical norms as we seek to accelerate investment in and adoption of personalized medicine.
We have an opportunity [with personalized medicine] to [improve] health care, but we need to get past the status quo.”— Michael Sherman, M.D., Chief Medical Officer, Senior Vice President, Harvard Pilgrim Health Care
The successful implementation of [personalized medicine] will depend on the embrace of [its] principles in the business community.”— Raju Kucherlapati, Ph.D., Paul C. Cabot Professor of Genetics, Harvard Medical School
Amy P. Abernethy, M.D., Ph.D.
Chief Medical Officer, Chief Scientific Officer
Donna R. Cryer, J.D.
President, Chief Executive Officer
Global Liver Institute
Luba Greenwood, J.D.
Strategic Business Development and Corporate Ventures
Verily, an Alphabet Company
David King, J.D.
Daniel P. O’Day, M.B.A.
Chief Executive Officer
Ellen V. Sigal, Ph.D.
Friends of Cancer Research
A. Keith Stewart, M.B., CH.B.
Carlson and Nelson Endowed Director, Center for Individualized Medicine
Liisa-Maria Voipio-Pulkki, M.D., Ph.D.
Director General, Chief Medical Officer, Ministry of Social Affairs and Health